Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors
|
|
- Claud Payne
- 5 years ago
- Views:
Transcription
1 Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors Raffaele Tinelli, M.D., a Mario Malzoni, M.D., a Francesco Cosentino, M.D., a Ciro Perone, M.D., a Andrea Tinelli, M.D., a Antonio Malvasi, M.D., a and Ettore Cicinelli, M.D. b a Advanced Gynecological Endoscopy Center, Malzoni Medical Center, Avellino; and b Department of Obstetrics and Gynecology, University Medical School of Bari, Bari, Italy Objective: To outline the most recent information regarding conservative laparoscopic surgery for young women with borderline ovarian tumors. Design: Review article. Setting: Advanced Gynecological Endoscopy Center, Malzoni Medical Center, Avellino, Italy. Patient(s): Young women with low-stage borderline ovarian tumors who wish to preserve their fertility. Intervention(s): Conservative laparoscopic surgery with unilateral salpingo-oophorectomy or cystectomy. Main Outcome Measure(s): Recurrence rate and outcomes. Result(s): Laparoscopic cystectomy may have more chance of preserving a woman s fertility compared with adnexectomy because of the removal of less ovarian tissue. Its greatest danger is the risk of inadvertently leaving behind some malignant cells. Therefore, this procedure should be reserved for patients with previous unilateral salpingo-oophorectomy or when bilateral lesions are present to preserve at least some ovarian tissue. Conclusion(s): When borderline ovarian tumors are identified at surgery by intraoperative histology, the recommended conservative treatment should be laparoscopic salpingo-oophorectomy. Recurrence can be noted after this type of treatment, but the cases of recurrent disease can be detected with close follow-up and treated accordingly. For these reasons, careful selection of candidates for this kind of treatment is, of course, necessary and close follow-up is required. If these restrictions are rigorously applied, then fertility-sparing surgery may be considered a safe option for this pathology, but all laparoscopic procedures should be reserved for oncologic surgeons trained in extensive laparoscopic procedures. (Fertil Steril Ò 2009;92: Ó2009 by American Society for Reproductive Medicine.) Key Words: Borderline ovarian tumor, cystectomy, laparoscopy, recurrence, salpingo-oophorectomy A borderline tumor of the ovary is an epithelial tumor with a low rate of growth and a low potential to invade or metastasize (1, 2). They account for 10% 15% of all ovarian tumors (3, 4). In particular, this type of ovarian tumor is characterized by a degree of cellular proliferation (stratification of the epithelial lining of the papillae, and nuclear atypia and mitotic activity) in the absence of stromal invasion (5). The 1987 International Federation of Gynecology and Obstetrics classification was used for staging (6). Stage was recorded by using the macroscopic description during the surgical procedure and by reviewing pathology records. Stage I is defined as a tumor limited to one or both ovaries; stages II and III are defined by the presence of an ovarian borderline tumor in addition to pelvic (stage II) or abdominopelvic (stage III) peritoneal implants. Peritoneal implants were classified as noninvasive or invasive according to the absence or presence of stromal invasion of the peritoneum (7, 8). Received March 25, 2008; revised June 11, 2008; accepted July 9, 2008; published online September 15, RT. has nothing to disclose. M.M. has nothing to disclose. F.C. has nothing to disclose. C.P. has nothing to disclose. E.C. has nothing to disclose. D.I. has nothing to disclose. M.R. has nothing to disclose. Reprint requests: Raffaele Tinelli, M.D., Advanced Gynecological Endoscopy Center, Malzoni Medical Center, Avellino, Italy (FAX: ; raffaeletinelli@tiscali.it). Borderline epithelial ovarian tumors are generally discovered at an earlier stage than malignant tumors. They frequently affect young women in which conservative and minimally invasive surgery is required to preserve childbearing potential (9). Laparoscopy can be used to perform all the surgical procedures needed in patients with early borderline ovarian tumors (BOT), including excision (adnexectomy and hysterectomy) and staging (peritoneal biopsies, omentectomy, appendectomy in patients with mucinous tumors, and removal of pelvic and paraaortic lymph nodes, although this last procedure has generated controversy in recent years). Laparoscopic management seems feasible in early BOT (10 12). Laparoscopic treatment of adnexal masses has proved to be a safe and effective diagnostic and therapeutic tool in the hands of experienced laparoscopists (13). THERAPY All procedures are performed under general endotracheal anesthesia. The patient are usually placed in the dorsolithotomy position, with the legs in universal Allen stirrups. In addition, intraoperative lower extremity sequential compression devices for venous thrombosis prophylaxis are used. The entire procedure is performed through laparoscopy and all patients are given antibiotic prophylaxis (cefoxitin 736 Fertility and Sterility â Vol. 92, No. 2, August /09/$36.00 Copyright ª2009 American Society for Reproductive Medicine, Published by Elsevier Inc. doi: /j.fertnstert
2 2 g IV). The vaginal cavity is cleansed with povidone-iodine solution and a Foley catheter is placed in the bladder. After a carbon dioxide pneumoperitoneum by Veress needle is induced at the level of umbilicus, a 10-mm trocar that incorporates the zero-degree laparoscope is inserted through an umbilical vertical incision and the entrance into the abdominal cavity is made under direct visualization, The laparoscope is connected to a video monitor. Once the trocar has been safely introduced into the abdominal cavity, the intra-abdominal pressure is maintained at 15 mm Hg. Three suprapubic ancillary trocars are used: one 5-mm trocar is inserted in the midline 3 cm under the umbilicus, and one in each iliac fossa (5 mm on the left side and 10 mm on the right size) laterally to the inferior epigastric vessels. Before the operative procedure, all the pelvic structures are inspected and the abdomen explored through the laparoscope in a clockwise fashion. Guidelines for surgical treatment of BOT, in women who do not wish any other pregnancy, include peritoneal washing, hysterectomy with bilateral salpingo-oophorectomy, omentectomy, and multiple peritoneal biopsies (14 17). As has already been discussed, patients with BOT tend to be younger than women with invasive ovarian cancer. For many of these patients, fertility is an important issue. Previous studies have suggested the safety of conservative surgery with unilateral salpingo-oophorectomy or cystectomy for patients with stage I BOT. They are characterized by an excellent long-term survival (14, 18 20). The laparoscopic approach follows a standardized procedure. First, an observational time of adnexal masses in search of macroscopic findings suggestive of malignancy is performed. These features are: presence of extraovarian implants, presence of exophytic growth, anarchic vascularization on the surface of the ovary, and ascites (21). The laparoscopic surgery includes a cytologic evaluation of pelvic and abdominal washings and treatment of adnexal mass by cystectomy or unilateral salpingo-oophorectomy in accordance with recommendations for laparoscopic treatment of benign adnexal mass (21). Tissue is removed from the abdominal cavity using a plastic bag to reduce the possibility of parietal implantation of neoplastic cells. An intraoperative histologic examination on a frozen section preparation is carried out in all patients. Multiple pelvic and abdominal peritoneal and contralateral ovarian biopsies, cytologic evaluation of pelvic and abdominal washings, infracolonic omentectomy, and an accurate abdominal inspection to obtain the intraoperative staging of the disease are performed. Systematic appendectomy is also a criterion for complete staging of mucinous borderline tumors. If there are no obvious abdominal or pelvic peritoneal lesions, random peritoneal biopsies are performed. Laparoscopic salpingo-oophorectomy should be considered as the first choice of conservative treatment in most patients, because it seems to be associated with lower recurrence rates compared with laparoscopic cystectomy. The greatest risks of this procedure are cysts rupture, intra-abdominal spillage, and contamination of the abdominal wall. These risks can be reduced to an acceptable level by the use of a plastic bag, reducing the possibility of parietal implantation of neoplastic cells (13). The laparoscopic approach to borderline tumors, as any suspicious adnexal mass, should follow strict criteria to reduce the risk of spreading and relapse. Spillage should be minimized and in case of intraoperative rupture during laparoscopy or laparotomy, the treatment is the same: a copious washing of the pelvis and abdomen; manipulation of the tumor should be kept to the minimum; any biopsy specimen should be extracted with an endobag protecting the abdominal wall. Laparoscopic cystectomy may have more chance of preserving a woman s fertility compared with adnexectomy because of the removal of less ovarian tissue. Its greatest danger is the risk of inadvertently leaving behind some malignant cells. Therefore, this procedure should be reserved for patients with previous unilateral salpingo-oophorectomy or when bilateral lesions are present to preserve at least some ovarian tissue (13). If bilateral adnexal masses are present in a young patient wanting to preserve fertility, intraoperative decision making is more difficult. Before any resection, the ovarian masses should be carefully inspected and assessed for adjacent normal ovarian tissue. In general, the more suspicious ovary should be removed using the most conservative means on the contralateral side (ovarian cystectomy, if possible) and the specimens sent for frozen section analysis. If a borderline tumor is diagnosed, then either ovarian cystectomy or oophorectomy should be performed on the contralateral side (7, 8, 22, 23). The accuracy of frozen section diagnosis of ovarian tumors is important, especially in young women who may be managed conservatively with preservation of fertility. A recent series by Ilvan et al. (24) confirmed that frozen section diagnosis is a reliable method for the surgical management of BOT with a sensitivity of 87 % and a specificity of 98 %. However, diagnostic problems can occur in mucinous borderline tumors during frozen section examination (24). Although several investigators would recommend routine biopsy of a normal-appearing contralateral ovary, some investigators believe that careful macroscopic inspection of the normal ovary should be sufficient because unnecessary biopsy or wedge resection may result in peritoneal adhesions or ovarian failure (25). Darai et al. (26) reported a series of 25 patients with BOTs first treated by the laparoscopic approach. Among the 25 patients first treated by laparoscopic approach, 15 had conservative treatment and 10 had radical treatment. Three recurrences occurred after cystectomy. Twenty-three patients were alive without evidence of disease, one died of Fertility and Sterility â 737
3 intercurrent disease. Their data suggested that laparoscopic approach to BOTs is possible in early stage disease, but associated with a high risk of recurrence after cystectomy. Maneo et al. (27) evaluated the risk of the laparoscopic approach to patients with BOTs compared with the laparotomic management. Sixty-two patients had fertility-sparing surgery: 30 operated by laparoscopy, 32 by laparotomy. Rupture of the cyst was more frequent in the laparoscopic group. After a follow-up of 61 months for the laparoscopic group, they observed 11 patients (37%) with persistent disease after primary laparoscopy (Table 1). After primary laparotomy, no patients showed early persistence of tumor, and ovarian relapses were diagnosed in seven women (22%). They concluded that laparoscopic treatment of BOTs should be reserved to masses not more than 5 cm. When conservative therapy is desired, the entire affected ovary should be removed. If the neoplasia is bilateral, cystectomy could be allowed in women who wish to preserve fertility, although they are at high risk of relapse. Morice et al. (28) observed in their study the high proportion of patients (42.5%) with peritoneal implants (stage II or III disease). Of patients who were treated conservatively 27 % had a stage II or III disease. In patients with peritoneal implants, location (stage II or III) was less important than their characteristics (invasive or noninvasive) in terms of prognosis (7, 8). In a study by Gersherson et al. (7), 39 patients had invasive peritoneal implants, of which 30% developed into progressive or recurrent disease. At this potential rate TABLE 1 Recurrences after conservative surgery for borderline ovarian tumors: review of literature. Authors of study Patients Treatment Recurrences Darai et al. 25 Laparoscopy 3 Maneo et al. 30 Laparoscopy Laparotomy 7 Deffieux et al. 9 Laparoscopy 4 Romagnolo 113 Laparoscopy 13 et al. 61 Laparotomy Seracchioli 19 Laparoscopy 1 et al. Donnez et al. 3 Laparotomy 3 13 Laparoscopy Fauvet et al. 149 Laparoscopy Laparotomy 19 Boran et al. 56 Laparotomy 4 6 Laparoscopy Camatte 31 Laparoscopy 6 et al. Tinelli et al. 43 Laparoscopy 3 Total Tinelli. Treatment of borderline ovarian tumors. Fertil Steril of progression, performing conservative procedures in patients with invasive implants seems to put them at risk. In the series by Morice et al. (28), as reported by Tazelaar et al. (19), all patients with recurrence who initially received conservative treatment were alive and free of disease. No patients treated conservatively experienced recurrence in the form of invasive ovarian cancer and none of the 10 patients with noninvasive peritoneal implants who were treated conservatively experienced invasive recurrence. All recurrences were diagnosed during routine follow-up procedures (clinical examination or pelvic ultrasonography) and were treated with surgery. The only three patients who had a poor outcome had initial radical surgery, and therefore cannot be considered to have had failure of conservative treatment. Thus, even if conservative surgery increases the risk for ovarian recurrence of BOT tumor, recurrent disease is amenable to surgical treatment and patient survival is not affected by this conservative approach. Conservative treatment should therefore be considered safe only for treatment of younger patients with BOTs who will comply with routine follow-up (28). According to the literature, the most important prognostic factors of patients with advanced stage borderline tumor are: [1] the histologic characteristic of the implants (noninvasive or invasive) and [2] the presence of residual disease at the end of the surgical procedure (7, 8, 28). The rate of recurrent invasive disease is significantly increased in patient with invasive peritoneal implants, compared with patients with noninvasive implants (28). Therefore, prognosis of patients with noninvasive implants is good (if a complete resection of peritoneal disease is performed) (29, 30). On the other hand, prognosis of patients with invasive implants is poor. According to these results, several investigators are more reticent to propose a conservative treatment in patients with invasive implants. To perform an accurate diagnosis of the peritoneal implants, the initial surgical procedure of borderline tumor should include a resection of all macroscopic peritoneal implants. Therefore the total removal of macroscopic implants in BOT has a diagnostic and therapeutic value. Boran et al. (31) observed that recurrence after cystectomy and adnexectomy was 15% and 2.4%, respectively. They suggested that the recommended conservative treatment should be unilateral oophorectomy, because the rate of recurrence after cystectomy was high. In a French multicenter study of 358 women with BOT, 149 women underwent laparoscopy. Conservative treatment and cyst rupture were more frequent in the laparoscopy group than in the laparoconversion and laparotomy groups. No difference in the recurrence rate was noted between the groups, but a higher recurrence rate was observed after conservative treatment. Laparoscopic management of BOTs is associated with a higher rate of cyst rupture and incomplete staging. Recurrence was more frequent after conservative treatment (32). Deffieux et al. (33) reported the clinical outcomes of laparoscopic treatment of BOTs with peritoneal implants for stage II or stage III BOT. Nine patients underwent 738 Tinelli et al. Treatment of borderline ovarian tumors Vol. 92, No. 2, August 2009
4 a laparoscopic treatment of stage II/III serous borderline tumor. A conservative management was performed in seven patients. There was a recurrence in four patients. Three spontaneous pregnancies were observed. All patients were alive without evidence of disease with a median follow-up of 35 months after the laparoscopic treatment. Their series suggested that laparoscopic treatment of patients with BOT associated with noninvasive implants is feasible and seems to be safe. Romagnolo et al. (34) reported 113 patients affected by low malignant ovarian tumor who were operated by laparoscopic surgery. Fifty-three patients (46.9%) underwent fertility-sparing surgery to preserve their childbearing potential. In 22/113 (19.5%) cases, they observed tumor rupture or spilling during surgery, and this incidence was greater in the group of patients treated by laparoscopy compared with laparotomy. In 13 (11.5%) patients they observed a relapse, although there was a difference in relapse rate according to the type of the surgical approach: 7% for radical and 17% for conservative therapy. Type of surgical approach, laparoscopic versus laparotomic, did not seem to influence the progression-free survival. When cystectomy was performed, the progression-free survival was significantly lower when compared with nonconservative surgery or unilateral salpingo-oophorectomy. Eight pregnancies were observed. The investigators concluded that conservative laparoscopic surgery may be the treatment of choice, but this surgery should be reserved for oncologic surgeons trained in extensive laparoscopic procedures to obtain a correct surgical staging and better results in terms of both relapse-free survival and pregnancies (34). Seracchioli et al. (13) suggested that a limited laparoscopic approach to the surgical management of BOT may be safe. They treated 19 reproductive-age women by laparoscopic cystectomy or unilateral salpingo-oophorectomy. A limited staging was performed that included a careful exploration of the peritoneal cavity, washings, targeted peritoneal biopsies, and biopsy of the controlateral ovary. At a mean follow-up of months, only one patient had a recurrence. She recurred in the same ovary after a cystectomy for her initial tumor, and was treated with repeat cystectomy. There were six spontaneous pregnancies, and all went to term (13). Donnez et al. (35) reported a recurrence after adnexectomy with contralateral cystectomy. They reported 12 pregnancies in 7 of 11 women who underwent fertility-sparing management and who wished to become pregnant. For women who are treated conservatively, follow-up is important. Zanetta et al. (36) evaluated physical examination, pelvic ultrasonography, and CA125 levels to determine the best modality for following patients after conservative treatment for BOT. Patients were evaluated every 3 months for the first 2 years and then every 6 months thereafter. Of 164 women treated with fertility-sparing surgery, 28 (17%) recurred. The investigators concluded that using all three modalities, pelvic examination, pelvic ultrasound, and CA125 measurements, would seem to be the most prudent approach. Camatte et al. (30) reported 34 patients who underwent laparoscopic treatment for BOT. Conservative treatment was performed in 31 (91%) patients. After a median follow-up time of 45 months, six (17%) patients recurred (5 of whom in the remaining ovary after conservative surgery and in the peritoneum in 1 patient). Two port-site metastases were observed. Nine spontaneous pregnancies were observed in 6 patients from a group of 15 patients desiring pregnancy. In our recent study of women with BOT, among 43 women who underwent conservative surgery, 21 (49%) became pregnant during the follow-up period. Among the three patients (7%) who developed recurrences after conservative surgery, two occurred after cystectomy and one after oophorectomy, but all the recurrences did not occur in the cases of intraoperative rupture of cyst. The histologic type of recurrences was similar to the primary tumor (37). According to a recent study in 317 women with diagnosis of borderline tumor of the ovary (38), which showed an incidence of retroperitoneal metastasis of 3,7% and lymph node recurrence of 0.4% after a median follow-up exceeding 6 years, lymph node sampling as part of the staging procedures is not routinely performed (38). The influence of lymph node removal on outcomes seems small. In the absence of lymph node removal, less than 1% of patients experienced lymph node recurrences (30, 39). At present, complete staging has not been shown to improve survival. In a study by Winter et al. (40), the overall 5-year survival and recurrence rates were similar with or without lymphadenectomy. Thus, in patients with apparently early-stage BOT, the outcomes seem more heavily dependent on histology than on the extent of surgery. Serous micropapillary tumors and microinvasive tumors have been associated with poorer outcomes (41). The presence of peritoneal implants may be the most significant prognostic factor (42). Removal of the remaining ovary should be performed once childbearing is no longer a consideration, to reduce the risk of recurrent contralateral lesions (28, 35). The remaining ovarian cortex may be cryopreserved with recommendations previously described. Although the recommendation that all women who are conservatively managed should have the contralateral ovary removed after childbearing is not, at present, standard care, but it seems reasonable to us, as to other investigators (28, 29), to propose this, knowing that there are fewer recurrences with bilateral oophorectomy. Zanetta et al. (29) also noted a significantly higher rate of recurrence in the spared ovary after conservative surgery when compared with radical surgery. In their large series, the recurrence rate was 15.2% and 2.5%, respectively, after conservative and radical surgery for stage I disease, and 40% and 12.9% for stage II. They also concluded that in Fertility and Sterility â 739
5 young women wishing to preserve fertility, a conservative approach is reasonable, followed, in some cases, by definitive surgery after successful pregnancies. CONCLUSION In our opinion, conservative laparoscopic treatment of BOT is an appropriate and reasonable therapeutic option for young women with low-stage disease who wish to preserve their childbearing potential because the fertility results are encouraging. Recurrence can be noted after this type of treatment, but the cases of recurrent disease can be detected with close follow-up and treated accordingly. For these reasons, careful selection of candidates for this kind of treatment is, of course, necessary and close follow-up is required. Whenever possible, the treatment options for each possible operative finding should be discussed thoroughly with the patient and her family, including the advantages and disadvantages of each treatment approach. The main objective of conservative treatment for women with BOT is to spare fertility without negatively affecting overall and disease-free survival. Our results are in keeping with previous studies in which recurrence rates were higher after cystectomy than after unilateral salpingo-oophorectomy (17, 30, 31, 34, 35, 37, 43, 44). This suggests that laparoscopic cystectomy should be considered only for women with one ovary or with bilateral tumors who wish to preserve their childbearing potential. When BOTs are identified at surgery by intraoperative histology, the recommended conservative treatment should be laparoscopic salpingo-oophorectomy. If these restrictions are rigorously applied, then fertilitysparing surgery may be considered a safe option for this pathology, but all laparoscopic procedures should be reserved for oncologic surgeons trained in extensive laparoscopic procedures. REFERENCES 1. Trope C, Kaern J. Prognosis and management of borderline tumours of the ovary. Curr Opin Obstet Gynecol 1996;8: Harris R, Whittemore A, Itnyre J. Collaborative Ovarian Cancer Group. Characteristics relating to ovarian risk: a collaborative analysis of 12 US case-control studies. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136: Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to A review of clinicopathologic features and treatment modalities. Cancer 1993;71: Bell DA. Ovarian surface epithelial-stromal tumors. Hum Pathol 1991;22: Snider D, Stuart G, Nation J. Evaluation of surgical staging in stage 1 low malignant potential ovarian tumours. Gynecol Oncol 1991;40: International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987;156: Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C. Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 1998;82: Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Serous borderline tumors of the ovary with non invasive peritoneal implants. Cancer 1998;83: Leminen A, Lehtovirta P. Spread of ovarian cancer after laparoscopic surgery: report of eight cases. Gynecol Oncol 1999;75: Bostwick DG, Tazelaar HD, Ballon SC. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 1986;58: Rice LW, Berkowitz RS, Mark SD. Epithelial ovarian tumours of borderline malignancy. Gynecol Oncol 1990;39: Gershenson DM. Contemporary management of borderline ovarian tumors. Cancer Invest 1999;17: Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 2001;76: Yagizi R, Sandstad J, Munoz AK. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988;31: Creasman WT, Park R, Norris H. Stage I borderline ovarian tumors. Obstet Gynecol 1982;59: Hopkins MP, Morley GW. The second-look operation and surgical reexploration in ovarian tumors of low malignant potential. Obstet Gynecol 1989;74: Bonazzi C, Colombo N, Mangioni C. Neoplasie dell ovaio. In Medicina oncologica. Masson, Milan. 1994; Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis and transformation to invasive serous carcinoma. Cancer 1996;78: Tazeelar HD, Bostwick DG, Ballon SC. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985;66: Barnhill DR, Kurman RJ, Brady MF. Preliminary analysis of the behaviour of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13: Mage C, Canis M, Manhes H. Laparoscopic management of adnexal cystic masses. J Gynecol Surg 1990;6: Morris RT, Gershenson DM, Silva EG, Follen M, Morris M, Wharton JT. Outcome and reproductive function after conservative surgery for borderline ovarian tumors. Obstet Gynecol 2000;95: Wakahara F, Kikkawa F, Nawa A, Tamakoshi K, Ino K, Maeda O, et al. Diagnostic efficacy of tumor markers, sonography, and intra-operative frozen section for ovarian tumors. Gynecol Obstet Invest 2001;52: Ilvan S, Ramazanoglu R, Ulker Akyildiz E, Calay Z, Bese T, Oruc N. The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses. Gynecol Oncol 2005;97: Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of serous borderline ovarian tumors. Cancer 1999;85: Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998;77: Maneo A, Vignali M, Chiari S, Colombo A, Mangioni C, Landoni F. Are borderline tumors of the ovary safely treated by laparoscopy? Gynecol Oncol 2004;94: Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001;75: Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001;19: Camatte S, Morice P, Atallah D, Thoury A, Pautier P, Lhomme C, et al. Clinical outcome after laparoscopic pure management of borderline ovarian tumors: results of a series of 34 patients. Ann Oncol 2004;15: Tinelli et al. Treatment of borderline ovarian tumors Vol. 92, No. 2, August 2009
6 31. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 2005;97: Fauvet R, Boccara J, Dufournet C, Poncelet C, Darai E. Laparoscopic management of borderline ovarian tumors: results of a French multicenter study. Ann Oncol 2005;16: Deffieux X, Morice P, Camatte S, Fourchotte V, Duvillard P, Castaigne D. Results after laparoscopic management of serous borderline tumor of the ovary with peritoneal implants. Gynecol Oncol 2005;97: Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T. Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 2006;101: Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003;79: Zanetta G, Rota S, Lissoni A. Ultrasound, physical examination, and CA125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors. Gynecol Oncol 2001;81: Tinelli FG, Tinelli R, La Grotta F, Tinelli A, Cicinelli E, Sch onauer MM. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors. Acta Obstet Gynecol Scand 2007;86: Nezhat C, Nezhat F, Burrel M. Laparoscopically assisted hysterectomy for the management of a borderline ovarian tumor: a case report. J Laparoendosc Surg 1992;2: Rota SM, Zanetta G, Ieda N, Rossi R, Chiari S, Perego P, et al. Clinical relevance of retroperitoneal involvement from epithelial ovarian tumors of borderline malignancy. Int J Gynecol Cancer 1999;9: Winter WE, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL. Surgical staging in patients with ovarian tumours of low malignant potential. Obstet Gynecol 2002;100: Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumours. Am J Surg Pathol 1996;20: Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26: Lim Tan SK, Cajigas HE, Scully R. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988;72: Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 2006;100: Fertility and Sterility â 741
Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors
REPRODUCTIVE SURGERY Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors Yoav Yinon, M.D., Mario E. Beiner, M.D., Walter
More informationUnilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian tumors
Available online at www.sciencedirect.com Journal of the Chinese Medical Association 74 (2011) 250e254 Original Article Unilateral salpingo-oophorectomy as fertility-sparing surgery for borderline ovarian
More informationSurvival Analysis and Prognosis for Patients with Serous and Mucinous Borderline Ovarian Tumors: 14-Year Experience from a Tertiary Center in Iran
ORIGINAL ARTICLE Survival Analysis and Prognosis for Patients with Serous and Mucinous Borderline Ovarian Tumors: 14-Year Experience from a Tertiary Center in Iran Katayoun Ziari, Ebrahim Soleymani, and
More informationBorderline Ovarian Tumours. Andreas Obermair Brisbane
Borderline Ovarian Tumours Andreas Obermair Brisbane Definition First described in 1929 Cellular features of malignancy Cellular atypia Mitotic activity No stromal invasion An entity per se??? (or precursor
More informationOutcome and Reproductive Function After Conservative Surgery for Borderline Ovarian Tumors
Outcome and Reproductive Function After Conservative Surgery for Borderline Ovarian Tumors ROBERT T. MORRIS, MD, DAVID M. GERSHENSON, MD, ELVIO G. SILVA, MD, MICHELE FOLLEN, MD, MITCHELL MORRIS, MD, AND
More informationFertility Preservation Is Safe for Serous Borderline Ovarian Tumors
ORIGINAL STUDY Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors Eveline Vancraeynest, MD,* Philippe Moerman, MD, PhD,Þ Karin Leunen, MD, PhD,* Frédéric Amant, MD, PhD,* Patrick Neven,
More informationSurgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy
Acta Obstetricia et Gynecologica. 2007; 86: 620 626 ORIGINAL ARTICLE Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy ELIN ØDEGAARD
More informationThe impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients ( 40 years old) with borderline ovarian tumors
Fang et al. BMC Cancer (2018) 18:1147 https://doi.org/10.1186/s12885-018-4932-2 RESEARCH ARTICLE Open Access The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients
More informationBorderline tumors of the ovary: a separate entity
Borderline tumors of the ovary: a separate entity Authors Key words A.Ph. Makar Excellent prognosis, conservative surgery, adjuvant therapy Summary Borderline ovarian tumors (BOT) account for 10% to 20%
More informationChapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationC. Poncelet, R. Fauvet, C. Yazbeck, C. Coutant, E. Darai. To cite this version: HAL Id: hal
Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: Multivariate analysis of a french multicentre study C. Poncelet, R. Fauvet, C. Yazbeck, C. Coutant,
More informationClinical Study Laparoscopic Surgery in Elderly Patients Aged 65 Years and Older with Gynecologic Disease
International Scholarly Research Network ISRN Obstetrics and Gynecology Volume 2012, Article ID 678201, 4 pages doi:10.5402/2012/678201 Clinical Study Laparoscopic Surgery in Elderly Patients Aged 65 Years
More informationGestione dei tumori borderline iniziali e avanzati nelle donne in età fertile
Gestione dei tumori borderline iniziali e avanzati nelle donne in età fertile Pierandrea De Iaco pierandrea.deiaco@aosp.bo.it SSD ONCOLOGIA GINECOLOGICA AOU SANT ORSOLA-MALPIGHI BOLOGNA Borderline ovarian
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/24096
More informationIMMATURE TERATOMA: SURGICAL TREATMENT
CARAVAGGIO 10-12 MAGGIO 2010 IMMATURE TERATOMA: SURGICAL TREATMENT G. Mangili, E. Garavaglia, C. Sigismondi R VIGANO Dipartimento Materno Infantile, UF Ginecologia Oncologica IRCCS San Raffaele Milano
More informationA Serous Borderline Tumor of the Fallopian Tube Detected Incidentally
A Serous Borderline Tumor of the Fallopian Tube Detected Incidentally Imrana Tanvir, Ghania Ali, Haseeb Ahmed Khan and Ahmed Nasir Hanifi* Dept. of Histopathology, FMH College of Medicine & Dentistry,
More informationPLACE AND MODALITIES OF LAPAROSCOPY IN SURGICAL MANAGEMENT OF SUSPECTED ADNEXAL MASSES
[Frontiers in Bioscience 1, g5-11, 1 December 1996] PLACE AND MODALITIES OF LAPAROSCOPY IN SURGICAL MANAGEMENT OF SUSPECTED ADNEXAL MASSES Charles Chapron 1, Jean-Bernard Dubuisson, Sylvie Capella-Allouc
More informationOriginal contribution
Human Pathology (2012) 43, 747 752 www.elsevier.com/locate/humpath Original contribution The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher
More informationLAPAROSCOPY and OVARIAN CANCER
LAPAROSCOPY and OVARIAN CANCER J. DAUPLAT Clermont-Ferrand France UNIVERSITÉ D'AUVERGNE CLERMONT 1 1 - PROPHYLACTIC OOPHORECTOMY 2 - DIAGNOSIS 3 - EARLY STAGES : STAGING 4 - ADVANCED STAGES - ASSESSMENT
More informationPrognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases
J Gynecol Oncol Vol. 20, No. 3:158-163, September 2009 DOI:10.3802/jgo.2009.20.3.158 Original Article Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases
More informationPredictive value of CA 125 and CA 72-4 in ovarian borderline tumors
Article in press - uncorrected proof Clin Chem Lab Med 2009;47(5):537 542 2009 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2009.134 2009/623 Predictive value of CA 125 and CA 72-4 in ovarian
More informationPort-Site Metastases After Robotic Surgery for Gynecologic Malignancy
SCIENTIFIC PAPER Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy Noah Rindos, MD, Christine L. Curry, MD, PhD, Rami Tabbarah, MD, Valena Wright, MD ABSTRACT Background and Objectives:
More informationSurgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT)
Trillsch et al. Journal of Ovarian Research 2013, 6:48 RESEARCH Open Access Surgical management and perioperative morbidity of patients with primary borderline ovarian tumor (BOT) Fabian Trillsch 1, Jan
More informationBorderline tumors. Borderline tumors. Serous borderline tumor are NOT benign. Low grade serous carcinoma: pathogenesis. Serous carcinoma: pathogenesis
Serous borderline tumor are NOT benign Robert A. Soslow, MD Memorial Sloan-Kettering Cancer Center soslowr@mskcc.org Borderline tumors Serous BTs and seromucinous BTs are both histopathologically borderline
More informationA Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants
Gynecologic Oncology A Meta-Analysis on the Impact of Platinum-Based Adjuvant Treatment on the Outcome of Borderline Ovarian Tumors With Invasive Implants INES VASCONCELOS,JESSICA OLSCHEWSKI,IOANA BRAICU,JALID
More informationDavid Nunns on behalf of the Gynae Guidelines Group Date:
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Borderline tumours of the ovary management and follow-up Author: Contact Name and Job Title Directorate & Speciality
More informationLow-grade serous neoplasia. Robert A. Soslow, MD
Low-grade serous neoplasia Robert A. Soslow, MD soslowr@mskcc.org Outline Orientation Ovarian tumor overview Non serous borderline tumors Serous borderline tumors Clinical summary Morphologic description
More informationClinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122
Ovarian cancer: recognition and initial management Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationSEROUS TUMORS. Dr. Jaime Prat. Hospital de la Santa Creu i Sant Pau. Universitat Autònoma de Barcelona
SEROUS TUMORS Dr. Jaime Prat Hospital de la Santa Creu i Sant Pau Universitat Autònoma de Barcelona Serous Borderline Tumors (SBTs) Somatic genetics Clonality studies have attempted to dilucidate whether
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationSquamous cell carcinoma arising in a dermoid cyst of the ovary: a case series
DOI: 10.1111/j.1471-0528.2007.01478.x www.blackwellpublishing.com/bjog Gynaecological oncology Squamous cell carcinoma arising in a dermoid cyst of the ovary: a case series JL Hurwitz, a A Fenton, a WG
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationClear cell carcinoma arising from abdominal wall endometriosis: a unique case with bladder and lymph node metastasis
Liu et al. World Journal of Surgical Oncology 2014, 12:51 WORLD JOURNAL OF SURGICAL ONCOLOGY CASE REPORT Open Access Clear cell carcinoma arising from abdominal wall endometriosis: a unique case with bladder
More informationHJOG. Fertility sparing options for women with ovarian neoplasms. Review. Abstract
HJOG An Obstetrics and Gynecology International Journal Review Fertility sparing options for women with ovarian neoplasms Zygouris Dimitrios 1, Panagopoulos Perikles 1, Christodoulaki Chrysi 1, Vrachnis
More informationLaparoscopy has dramatically altered management of many gynecologic malignancies, but its utility in ovarian cancer has been limited until now.
OBG MANAGEMENT Minimally invasive surgery in ovarian cancer Laparoscopy has dramatically altered management of many gynecologic malignancies, but its utility in ovarian cancer has been limited until now.
More informationMucinous Tumors of the Ovary Beirut, Lebanon. Anaís Malpica, M.D. Professor Department of Pathology
Mucinous Tumors of the Ovary Beirut, Lebanon Anaís Malpica, M.D. Professor Department of Pathology Primary Mucinous Tumors of the Ovary Cystadenoma Borderline (Tumor of Low Malignant Potential/Atypical
More informationLaparoscopic Management of Early Stage Endometrial Cancer. B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G.
Laparoscopic Management of Early Stage Endometrial Cancer B. Rabischong, M. Canis, G. Le Bouedec, C. Pomel, J.L Achard, J. Dauplat, G. Mage Early Stage of Endometrial Cancer most of cases diagnosed (clinical
More informationLaparoscopic versus laparotomic surgery for adnexal masses: role in elderly
Pulcinelli et al. World Journal of Surgical Oncology (2016) 14:105 DOI 10.1186/s12957-016-0861-1 RESEARCH Open Access Laparoscopic versus laparotomic surgery for adnexal masses: role in elderly F. M. Pulcinelli
More informationBibliography. Serous Tumors of the Ovary. Nomenclature
Bibliography Serous Tumors of the Ovary Nomenclature 1. Allison KH, Swisher EM, Kerkering KM, et al. Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is
More informationبسم هللا الرحمن الرحيم. Prof soha Talaat
بسم هللا الرحمن الرحيم Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible
More informationRecurrence of sex cord tumor with annular tubules in young patient with Peutz-Jeghers syndrome
Slimane et al. 74 CASE REPORT PEER REVIEWED OPEN ACCESS Recurrence of sex cord tumor with annular tubules in young patient with Peutz-Jeghers syndrome Meher Slimane, Selma Gadria, Manel Hadidane, Houyem
More informationConsent Advice No. XX (Joint with BSGE) Peer Review Draft Spring Morcellation for Laparoscopic Myomectomy or Hysterectomy
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Consent Advice No. XX (Joint with BSGE) Peer Review Draft
More informationCase # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor
Case # 4 Low-Grade Serous Carcinoma (Macropapillary) of the Ovary Arising in an Atypical Proliferative Serous Tumor Robert J Kurman, M.D. Johns Hopkins University School of Medicine Case History A 53 year
More informationFERTILITY SPARING IN ENDOMETRIAL CANCER
FERTILITY SPARING IN ENDOMETRIAL CANCER Prof. Dr. Bülent Özçelik Erciyes University Medical Faculty Department of Obstetrics and Gynecology Gynecologic Oncology Unit Endometrial Cancer Most frequent gynecologic
More informationCase Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue
Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More informationOvarian serous tumors of low malignant potential
ORIGINAL ARTICLE Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors) Pathology, Prognosis, and Proposed Classification Jesse K. McKenney, MD, Bonnie L. Balzer,
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationA Survay on Appendiceal Involvement in Ovarian Mucinous Tumors
http://www.ijwhr.net Open Access doi 10.15296/ijwhr.2018.33 Original Article International Journal of Women s Health and Reproduction Sciences Vol. 6, No. 2, April 2018, 199 203 ISSN 2330-4456 A Survay
More informationSerous Borderline Tumors of the Ovary: Implants, Manifestations, Biology & New Insights in Progression
Serous Borderline Tumors of the Ovary: Implants, Manifestations, Biology & New Insights in Progression Stanley J. Robboy, MD Professor of Pathology Professor of Obstetrics & Gynecology Vice Chairman for
More informationLaparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies
Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies Ludovico Muzii, M.D., a Innocenza Palaia, M.D., b Milena Sansone, M.D., b Marco Calcagno, M.D., b Francesco Plotti,
More informationX-Plain Ovarian Cancer Reference Summary
X-Plain Ovarian Cancer Reference Summary Introduction Ovarian cancer is fairly rare. Ovarian cancer usually occurs in women who are over 50 years old and it may sometimes be hereditary. This reference
More informationAmerican Journal of Oral Medicine and Radiology
American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr ULTRASONOGRAPHIC EVALUATION OF ADNEXAL MASSES Nageswar Rao* Professor,
More informationSignificance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma
ORIGINAL STUDY Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma Jeong-Yeol Park, MD, PhD, Dae-Yeon Kim, MD, PhD, Dae-Shik Suh, MD, PhD, Jong-Hyeok Kim, MD, PhD, Yong-Man
More informationOvarian Tumors. Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center
Ovarian Tumors Andrea Hayes-Jordan MD FACS, FAAP Section Chief, Pediatric Surgery/Surgical Onc. UT MD Anderson Cancer Center Case 13yo female with abdominal pain Ultrasound shows huge ovarian mass Surgeon
More informationLow-Grade Serous Ovarian Tumors Debra A. Bell, MD Mayo Clinic and Mayo Medical School Rochester, MN
1 Low-Grade Serous Ovarian Tumors Debra A. Bell, MD Mayo Clinic and Mayo Medical School Rochester, MN It is very appropriate to discuss low-grade ovarian serous neoplasms in a symposium in honor of Dr.
More informationRESEARCH ARTICLE. Usanee Chatchotikawong 1, Irene Ruengkhachorn 1 *, Chairat Leelaphatanadit 1, Nisarat Phithakwatchara 2. Abstract.
RESEARCH ARTICLE 8-year Analysis of the Prevalence of Lymph Nodes Metastasis, Oncologic and Pregnancy Outcomes in Apparent Early-Stage Malignant Ovarian Germ Cell Tumors Usanee Chatchotikawong 1, Irene
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More informationLaparoscopic Surgical Management and Clinical Characteristics of Ovarian Fibromas
SCIENTIFIC PAPER Laparoscopic Surgical Management and Clinical Characteristics of Ovarian Fibromas Chang Eop Son, MD, Joong Sub Choi, MD, Jung Hun Lee, MD, Seung Wook Jeon, MD, Jin Hwa Hong, MD, Jong Woon
More informationPregnancy With Huge Ovarian Cyst
BMH Med. J. 2018;5(3):74-78 Case Report Pregnancy With Huge Ovarian Cyst Suja Ann Ranji, Usha Payyodi, Ani Praveen, Rajesh MC, Jini Chandran Baby Memorial Hospital, Kozhikode 673004 Address for Correspondence:
More informationDiagnosi, inquadramento clinico e chirurgia
Tumori germinali, stromali e forme rare : stato dell arte, novità e prospettive Caravaggio 10-12 giugno 2010 Giorgia Mangili IRCCS San Raffaele Milano Diagnosi, inquadramento clinico e chirurgia SEX-CORD
More informationLaparoscopic Management of Ovarian Dysgerminoma Presenting with Acute Abdomen Caused by Adnexal Torsion in a 17-Year-Old Girl
J Pediatr Adolesc Gynecol (2009) 22:e9ee13 Case Reports Laparoscopic Management of Ovarian Dysgerminoma Presenting with Acute Abdomen Caused by Adnexal Torsion in a 17-Year-Old Girl Akihiro Takeda, MD,
More informationINTRODUCTION Ovarian cancer is the leading cause of mortality from gynecologic malignancies in the industrialized countries and is responsible for
INTRODUCTION Ovarian cancer is the leading cause of mortality from gynecologic malignancies in the industrialized countries and is responsible for more deaths than both cervical and endometrial tumours.
More informationAccuracy of ultrasound subjective pattern recognition for the diagnosis of borderline ovarian tumors
Ultrasound Obstet Gynecol 2007; 29: 489 495 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.4002 Accuracy of ultrasound subjective pattern recognition for the diagnosis
More informationRisk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
Jia et al. Journal of Ovarian Research (2018) 11:30 https://doi.org/10.1186/s13048-018-0405-0 RESEARCH Open Access Risk of synchronous endometrial disorders in women with endometrioid borderline tumors
More informationIndex. B Bilateral salpingo-oophorectomy (BSO), 69
A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell
More informationUnusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma
49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical
More informationDefinition Endometriosis is the presence of functioning endometrial tissue outside the cavity of the uterus.
Dept. of Obstetrics t and Gynecology Faculty of Medicine University of Sumatera Utara Endometriosis Definition Endometriosis is the presence of functioning endometrial tissue outside the cavity of the
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationAdjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 10-year Survivals
6 Adjuvant Chemotherapy in High Risk Patients after Wertheim Hysterectomy 0-year Survivals V Sivanesaratnam,*FAMM, FRCOG, FACS Abstract Although the primary operative mortality following radical hysterectomy
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationBorderline Ovarian Mucinous Tumors: Consensus Points and Persistent Controversies Regarding Nomenclature, Diagnostic Criteria, and Behavior
Borderline Ovarian Mucinous Tumors: Consensus Points and Persistent Controversies Regarding Nomenclature, Diagnostic Criteria, and Behavior Brigitte M. Ronnett, M.D.; C. Blake Gilks, M.D., Maria J. Merino,
More informationArticle begins on next page
Pseudopapillary Granulosa Cell Tumor: A Case of This Rare Subtype Rutgers University has made this article freely available. Please share how this access benefits you. Your story matters. [https://rucore.libraries.rutgers.edu/rutgers-lib/50622/story/]
More informationCNGOF Guidelines for the Management of Endometriosis
CNGOF Guidelines for the Management of Endometriosis Anatomoclinical forms of endometriosis Definitions Endometriosis is defined as the presence of endometrial tissue containing both glands and stroma
More informationOvarian Transposition for Stage Ib Squamous Cell Cervical Cancer - Lack of Effects on Survival Rates?
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.1.133 RESEARCH ARTICLE Ovarian Transposition for Stage Ib Squamous Cell Cervical Cancer - Lack of Effects on Survival Rates? A Taner Turan 1, H Levent Keskin
More informationEndometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationRole of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters
Naz et al. World Journal of Surgical Oncology (2015) 13:315 DOI 10.1186/s12957-015-0732-1 WORLD JOURNAL OF SURGICAL ONCOLOGY RESEARCH Open Access Role of peritoneal washing in ovarian malignancies: correlation
More informationBorderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
Gokcu et al. Journal of Ovarian Research (2016) 9:66 DOI 10.1186/s13048-016-0276-1 RESEARCH Open Access Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study
More informationIndex. B Bladder, injury of, Bowel, injury of, , Brachytherapy, for cervical cancer, 357 Burns, electrosurgical,
Perioperative Nursing Clinics 1 (2006) 375 379 Index Note: Page numbers of article titles are in boldface type. A Abdominal hysterectomy Acidosis, from insufflation, 323 Active electrode monitoring, in
More informationFacing Gynecologic Surgery?
Facing Gynecologic Surgery? Domenico Vitobello, MD Domenico Vitobello is the medical director of the Gynecologic Unit at the Humanitas Clinical and Research Center since 2009. He has developed a comprehensive
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationGynaecological Pathology Reporting. Peritoneal cytology Tony Williams Birmingham
Gynaecological Pathology Reporting Peritoneal cytology Tony Williams Birmingham Ascites Abdominopelvic peritoneal washings in gynaecological procedures Ovarian cyst aspirates Clinical guidance; RCOG &
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationMalignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years
Published online: September 21, 2013 1662 6575/13/0063 0480$38.00/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)
More informationUnexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine
Unexpected Gynecologic Findings at Laparotomy Susan A. Davidson, MD University of Colorado, Denver School of Medicine Adnexal Mass: Gyn Etiologies Uterine Leiomyomas Pregnancy Malignancy Tubal Pregnancy
More informationFDG-PET/CT in Gynaecologic Cancers
Friday, August 31, 2012 Session 6, 9:00-9:30 FDG-PET/CT in Gynaecologic Cancers (Uterine) cervical cancer Endometrial cancer & Uterine sarcomas Ovarian cancer Little mermaid (Edvard Eriksen 1913) honoring
More informationDiagnostic Laparoscopy
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at ChiaYi 嘉義長庚紀念醫院婦產科 Clinical Guideline Diagnostic Laparoscopy By Dr. CJ Tseng Diagnostic laparoscopy is a minimally invasive surgical
More informationLong-term Follow-up of Borderline Ovarian Tumors Clinical Outcome and Prognostic Factors
Long-term Follow-up of Borderline Ovarian Tumors Clinical Outcome and Prognostic Factors ANASTASIA LAZAROU 1, CHRISTINA FOTOPOULOU 2, ALEXANDRA COUMBOS 3, JALID SEHOULI 2, JEKATERINA VASILJEVA 4, IOANA
More informationMUSCLE - INVASIVE AND METASTATIC BLADDER CANCER
10 MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER Recommendations from the EAU Working Party on Muscle Invasive and Metastatic Bladder Cancer G. Jakse (chairman), F. Algaba, S. Fossa, A. Stenzl, C. Sternberg
More informationOUTCOMES OF ROBOTIC, LAPAROSCOPIC AND OPEN ABDOMINAL HYSTERECTOMY FOR BENING CONDITIONS IN OBESE PATIENTS
OUTCOMES OF ROBOTIC, LAPAROSCOPIC AND OPEN ABDOMINAL HYSTERECTOMY FOR BENING CONDITIONS IN OBESE PATIENTS Omer L. Tapisiz, Tufan Oge, Ibrahim Alanbay, Mostafa Borahay, Gokhan S. Kilic Department of Obstetrics
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationOvarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors
Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors Overview Ovarian epithelial cancer, fallopian tube cancer, and primary peritoneal cancer are
More informationOriginal Article Transvaginal sonographic characteristics of paraovarian borderline tumor
Int J Clin Exp Med 2015;8(2):2684-2688 www.ijcem.com /ISSN:1940-5901/IJCEM0004662 Original Article Transvaginal sonographic characteristics of paraovarian borderline tumor Fangui Zhao 1, Hao Zhang 2, Yunyun
More informationSurgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer
Ovarian cancer Surgical management and neoadjuvant chemotherapy for stage III-IV ovarian cancer JM. Classe, R. Rouzier, O.Glehen, P.Meeus, L.Gladieff, JM. Bereder, F Lécuru Suitable candidates for neo-adjuvant
More informationGeneral history. Basic Data : Age :62y/o Date of admitted: Married status : Married
General history Basic Data : Age :62y/o Date of admitted:940510 Married status : Married General history Chief Complain : bilateral ovarian cyst incidentally being found out during pap smear. Present Illness
More information